Reversal of human cellular senescence: roles of the p53 and p16 pathways
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
Telomere erosion and subsequent dysfunction limits the proliferation of normal human cells by a process termed replicative senescence. Replicative senescence is thought to suppress tumorigenesis by establishing an essentially irreversible growth arrest that requires activities of the p53 and pRB tumor suppressor proteins. We show that, depending on expression of the pRB regulator p16, replicative senescence is not necessarily irreversible. We used lentiviruses to express specific viral and cellular proteins in senescent human fibroblasts and mammary epithelial cells. Expression of telomerase did not reverse the senescence arrest. However, cells with low levels of p16 at senescence resumed robust growth upon p53 inactivation, and limited growth upon expression of oncogenic RAS. In contrast, cells with high levels of p16 at senescence failed to proliferate upon p53 inactivation or RAS expression, although they re-entered the cell cycle without growth after pRB inactivation. Our results indicate that the senescence response to telomere dysfunction is reversible and is maintained primarily by p53. However, p16 provides a dominant second barrier to the unlimited growth of human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“p16, an inhibitor of CDK4 and CDK6, is also key in several types of senescence26; p21 is activated early on senescence entry and p16 is activated later, probably to maintain the senescence phenotype27”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, cells that express low p16 INK4a levels (e.g., SEN(REP) or SEN(XRA) HCA2) senesce in response to severe damage by activating the p53 pathway; when p53 is subsequently inactivated in these cells, they resume proliferation [ 62 ], but do not lose the SASP.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This accumulation results in persistent activation of RB family proteins, inhibition of E2F transactivation, and consequent cell-cycle arrest, which, in time, cannot be reversed by subsequent inactivation of RB family proteins or p53 (Beause ´ jour et al., 2003).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In senescent cells, however, the CDK2 inhibitor p21 WAF1/Cip1 ( CDKN1A ) and CDK4/6 inhibitor p16 INK4A ( CDKN2A ) accumulate.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cell cycle controlling proteins p16, p21, and p53, normally inhibit cell cycle progression and have been shown to be accumulated in senescent cells [49–51].”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [51]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Self-citationSwitching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
Cited by
Items 501–600 of 1,003
Progeria, rapamycin and normal aging: recent breakthrough
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100352 · Cited by 50
Wong, J. C. T., Hasan, M. R., Rahman, M., Yu, A. C. Y., Chan, S. K., Schaeffer, D. F., Kennecke, H. F., Lim, H. J., Owen, D. A., & Tai, I. T. (2013) · International Journal of Cancer · doi:10.1002/ijc.28180 · Cited by 49
Herbig, U., Wei, W., Dutriaux, A., Jobling, W. A., & Sedivy, J. M. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00067.x · Cited by 50
Immortalization protocols used in cell culture models of human breast morphogenesis
Guðjónsson, Þ., Villadsen, R., Rønnov‐Jessen, L., & Petersen, O. W. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4167-z · Cited by 59
Potential Involvement of LOX-1 in Functional Consequences of Endothelial Senescence
Khaidakov, M., Wang, X., & Mehta, J. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020964 · Cited by 50
Madsen, S. D., Russell, K. C., Tucker, H. A., Glowacki, J., Bunnell, B. A., & O’Connor, K. C. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0649-4 · Cited by 50
Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells
Lafontaine, J., Cardin, G. B., Malaquin, N., Boisvert, J.-S., Rodier, F., & Wong, P. (2021) · Cancers · doi:10.3390/cancers13030386 · Cited by 54
Yu, X., Li, X.-H., Jiang, G., Wang, X., Chang, H. C., Hsu, W. H., & Li, Q. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.062 · Cited by 48
Marcoux, S., Le, O. N., Langlois-Pelletier, C., Laverdière, C., Hatami, A., Robaey, P., & Beauséjour, C. M. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-252 · Cited by 49
Jailbreak: Oncogene-induced senescence and its evasion
MDuff, F. K. E., & Turner, S. D. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.004 · Cited by 56
Boquoi, A., Arora, S., Chen, T., Litwin, S., Koh, J., & Enders, G. H. (2015) · Aging Cell · doi:10.1111/acel.12279 · Cited by 49
Deacetylation of H4-K16Ac and heterochromatin assembly in senescence
Contrepois, K., Thuret, J.-Y., Courbeyrette, R., Fenaille, F., & Mann, C. (2012) · Epigenetics & Chromatin · doi:10.1186/1756-8935-5-15 · Cited by 49
Role of lncRNAs in Cellular Aging
Degirmenci, U., & Sun, L. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00151 · Cited by 54
p53 induces senescence through Lamin A/C stabilization-mediated nuclear deformation
Yoon, M.-H., Kang, S., Lee, S. J., Woo, T., Oh, A.-Y., Park, S., Ha, N., & Park, B.-J. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1378-7 · Cited by 55
Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Mongiardi, M. P., Pellegrini, M., Pallini, R., Levi, A., & Falchetti, M. L. (2021) · Cancers · doi:10.3390/cancers13030484 · Cited by 53
Restoring Effects of Natural Anti-Oxidant Quercetin on Cellular Senescent Human Dermal Fibroblasts
Sohn, E.-J., Kim, J. M., Kang, S.-H., Kwon, J., An, H. J., Sung, J.-S., Cho, K. A., Jang, I.-S., & Choi, J.-S. (2018) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x18500453 · Cited by 48
Bhatia, B., Multani, A. S., Patrawala, L., Chen, X., Calhoun‐Davis, T., Zhou, J., Schroeder, L., Schneider‐Broussard, R., Shen, J., Pathak, S., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23222 · Cited by 47
p53: Pro-aging or pro-longevity?
de Keizer, P. L. J., Laberge, R.-M., & Campisi, J. (2010) · Aging · doi:10.18632/aging.100178 · Cited by 48
“As discussed above, p53 is an important regulator of cellular senescence [20], the essentially irreversible arrest of cell proliferation that occurs in response to potentially oncogenic stresses [21].”
BackgroundSelf-citationDespars, G., Carbonneau, C. L., Bardeau, P., Coutu, D. L., & Beausejour, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073206 · Cited by 52
Failure of cell cleavage induces senescence in tetraploid primary cells
Panopoulos, A., Pacios-Bras, C., Choi, J., Mythili, Y., Sussman, M. A., Fotedar, R., & Margolis, R. L. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-03-0844 · Cited by 52
Age-Related Changes of Claudin Expression in Mouse Liver, Kidney, and Pancreas
D'Souza, T., Sherman-Baust, C. A., Poosala, S., Mullin, J. M., & Morin, P. J. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp118 · Cited by 48
Evidence of oncogene-induced senescence in thyroid carcinogenesis
Vizioli, M. G., Possik, P. A., Tarantino, E., Meissl, K., Borrello, M. G., Miranda, C., Anania, M. C., Pagliardini, S., Seregni, E., Pierotti, M. A., et al. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0240 · Cited by 47
Richardson, M., & Richardson, D. R. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000803 · Cited by 51
Mirzayans, R., Andrais, B., Scott, A., Paterson, M. C., & Murray, D. L. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.22002 · Cited by 51
López-Vicente, L., Armengol, G., Pons, B., Coch, L., Argelaguet, E., LLeonart, M. E., Hernández‐Losa, J., de Torres, I. M., & y Cajal, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3159 · Cited by 54
Taschner‐Mandl, S., Schwarz, M., Blaha, J., Kauer, M. O., Kromp, F., Frank, N., Rifatbegovic, F., Weiss, T., Ladenstein, R. L., HOHENEGGER, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6527 · Cited by 49
Chen, J., Xu, T., Zhu, D., Wang, J., Huang, C., Lyu, L., Hu, B., Sun, W., & Duan, Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.228 · Cited by 47
Mouse Models of Accelerated Cellular Senescence
Yousefzadeh, M. J., Melos, K. I., Angelini, L., Burd, C. E., Robbins, P. D., & Niedernhofer, L. J. (2019) · Methods in Molecular Biology · doi:10.1007/978-1-4939-8931-7_17 · Cited by 47
Vančurová, M., Hanzlíková, H., Knoblochová, L., Kosla, J., Majera, D., Mistrík, M., Burdová, K., Hodný, Z., & Bártek, J. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.04.001 · Cited by 56
Stem cell: balancing aging and cancer
Krtolica, A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.007 · Cited by 47
Self-citationFunction of JunB in transient amplifying cell senescence and progression of human prostate cancer.
Konishi, N., Shimada, K., Nakamura, M., Ishida, E., Ota, I., Tanaka, N., & Fujimoto, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4120 · Cited by 46
Mao, G., Xing, W., Wen, X. L., Jia, B., Yang, Z. ‐., Wang, Y. ‐., Jin, X., Wang, G., & Yan, J. (2015) · International Journal of Cosmetic Science · doi:10.1111/ics.12202 · Cited by 50
Litwiniec, A., Grzanka, A., Helmin–Basa, A., Gackowska, L., & Grzanka, D. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0711-4 · Cited by 50
Oncogene-induced senescence: An essential role for Runx
Terry, A., Cameron, E., Neil, J., & Kilbey, A. (2008) · Cell Cycle · doi:10.4161/cc.6368 · Cited by 46
Senescent cells limit p53 activity via multiple mechanisms to remain viable
Sturmlechner, I., Sine, C. C., Jeganathan, K. B., Zhang, C., Fierro Velasco, R. O., Baker, D. J., Li, H., & van Deursen, J. M. (2022) · Nature Communications · doi:10.1038/s41467-022-31239-x · Cited by 45
Negri, T., Tarantino, E., Orsenigo, M., Reid, J. F., Gariboldi, M., Zambetti, M., Pierotti, M. A., & Pilotti, S. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20798 · Cited by 45
Cooperation between p53 and p130(Rb2) in induction of cellular senescence
Kapic, A., Helmbold, H., Reimer, R. A., Klotzsche, O., Deppert, W., & Bohn, W. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401756 · Cited by 50
Stepwise Neoplastic Transformation of a Telomerase Immortalized Fibroblast Cell Line
Zongaro, S., de Stanchina, E., Colombo, T., D’Incalci, M., Giulotto, E., & Mondello, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1140 · Cited by 53
Silva, G. C., Abbas, M., Khemais-Benkhiat, S., Burban, M., Ribeiro, T. P., Toti, F., Idris-Khodja, N., Côrtes, S. F., & Schini-Kerth, V. B. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.04.006 · Cited by 44
A dual role of HIF1α in regulating osteogenesis–angiogenesis coupling
Shao, J., Liu, S., Zhang, M., Chen, S., Gan, S., Chen, C., Chen, W., Li, L., & Zhu, Z. M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02742-1 · Cited by 44
Deregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 48
Biomarkers of ageing of humans and non-human primates
Wu, Z., Qu, J. T., Zhang, W., Bao, Z., Bi, Y., Cai, J.-P., Cai, S.-Q., Cao, C.-M., Cao, F., Cao, Z., et al. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00883-8 · Cited by 59
Wolyniec, K., Wotton, S., Kilbey, A., Jenkins, A., Terry, A., Peters, G., Stocking, C., Cameron, E., & Neil, J. C. (2009) · Oncogene · doi:10.1038/onc.2009.101 · Cited by 44
Rammah, M., Dandachi, F., Salman, R., Shihadeh, A., & El-Sabban, M. E. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.04.003 · Cited by 46
Sato, C., Iso, Y., Mizukami, T., Otabe, K., Sasai, M., Kurata, M., Sanbe, T., Sekiya, I., Miyazaki, A., & Suzuki, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.086 · Cited by 44
Mistriotis, P., Bajpai, V. K., Wang, X., Rong, N., Shahini, A., Asmani, M., Liang, M.-S., Wang, J., Lei, P., Liu, S., et al. (2016) · Stem Cells · doi:10.1002/stem.2452 · Cited by 46
Senescence and p130/Rbl2: a new beginning to the end
Fiorentino, F. P., Symonds, C. E., Macaluso, M., & Giordano, A. (2009) · Cell Research · doi:10.1038/cr.2009.96 · Cited by 48
Allan, G. J., Beattie, J., & Flint, D. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0269 · Cited by 56
Differential Oncogenic Ras Signaling and Senescence in Tumor Cells
Bihani, T., Mason, D. X., Jackson, T. J., Chen, S. C., Boettner, B., & Lin, A. W. (2004) · Cell Cycle · doi:10.4161/cc.3.9.1146 · Cited by 50
Single-cell transcriptomic analysis uncovers diverse and dynamic senescent cell populations
Wechter, N., Rossi, M., Anerillas, C., Tsitsipatis, D., Piao, Y., Fan, J., Martindale, J. L., De, S., Mazan-Mamczarz, K., & Gorospe, M. (2023) · Aging · doi:10.18632/aging.204666 · Cited by 43
The KEAP1–NRF2 pathway regulates TFEB/TFE3-dependent lysosomal biogenesis
Ong, A. J. S., Bladen, C. E., Tigani, T. A., Karamalakis, A. P., Evason, K. J., Brown, K., & Cox, A. G. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217425120 · Cited by 48
Nucleolar repression facilitates initiation and maintenance of senescence
Yang, L., Song, T., Chen, L., Soliman, H. H., & Chen, J. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1100777 · Cited by 46
Lowe, R., Overhoff, M. G., Ramagopalan, S. V., Garbe, J. C., Koh, J., Stampfer, M. R., Beach, D., Rakyan, V. K., & Bishop, C. L. (2015) · Genome biology · doi:10.1186/s13059-015-0748-4 · Cited by 50
DNA double strand break responses and chromatin alterations within the aging cell
Klement, K., & Goodarzi, A. A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.003 · Cited by 53
Sashida, G., Liu, Y., Elf, S., Miyata, Y., Ohyashiki, K., Izumi, M., Menéndez, S., & Nimer, S. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01551-08 · Cited by 44
Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer
Dahl, E. S., & Aird, K. M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00291 · Cited by 47
Cellular senescence: A pathogenic mechanism of pelvic organ prolapse (Review)
Huang, L., Zhao, Z., Wen, J., Ling, W., Miao, Y., & Wu, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11339 · Cited by 48
Kong, L., Dong, R., Huang, K., Wang, X., Wang, D., Yue, N., Wang, C., Sun, P., Gu, J., Luo, H., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153629 · Cited by 43
Age-Related Changes in the Fibroblastic Differon of the Dermis: Role in Skin Aging
Zorina, A. I., Zorin, V. L., Kudlay, D. A., & Kopnin, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116135 · Cited by 51
Liu, B., Liu, W., Liu, P., Liu, X., Song, X., Hayashi, T., Onodera, S., & Ikejima, T. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02816-2 · Cited by 44
Kang, X., Chen, L., Yang, S., Gong, Z., Hu, H., Zhang, X., Liang, C., & Xu, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115323 · Cited by 42
Benítez, S., Cordero, A., Santamaría, P. G., Redondo-Pedraza, J., Rocha, A. S., Collado-Solé, A., Jimenez, M., Sanz-Moreno, A., Yoldi, G., Santos, J. C., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.022 · Cited by 41
“There is a cellular state of light senescence, characterized by low levels of p16 that allows cells to resume proliferation following p53 inactivation (Beauséjour et al., 2003), different from a deep senescence state which is irreversible.”
BackgroundInsights from In Vivo Studies of Cellular Senescence
Prieto, L. I., Graves, S. I., & Baker, D. J. (2020) · Cells · doi:10.3390/cells9040954 · Cited by 41
“In accordance with these observations, the ablation of p53 in senescent human fibroblasts and mammary epithelial cells with low p16 expression allowed cell-cycle re-entry [9], which underscores the importance of p16 dynamics in cell-cycle arrest.”
ResultOjha, P. S., Maste, M. M., Tubachi, S. S., & Patil, V. S. (2022) · VirusDisease · doi:10.1007/s13337-022-00768-w · Cited by 56
Gregoire-Gauthier, J., Selleri, S., Fontaine, F., Dieng, M. M., Patey, N., Despars, G., Beausejour, C. M., & Haddad, É. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0413 · Cited by 41
Activation of hERG3 channel stimulates autophagy and promotes cellular senescence in melanoma
Perez‐Neut, M., Haar, L., Rao, V. R., Santha, S., Lansu, K., Rana, B., Jones, W. K., & Gentile, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7831 · Cited by 42
Hochegger, K., Koppelstaetter, C., Tagwerker, A., Huber, J. M., Heininger, D., Mayer, G., & Rosenkranz, A. R. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00084.2006 · Cited by 41
Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases
Udomsinprasert, W., Sobhonslidsuk, A., Jittikoon, J., Honsawek, S., & Chaikledkaew, U. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1992385 · Cited by 40
Helicobacter pylori ‐positive chronic atrophic gastritis and cellular senescence
Zheng, S., Zhu, L., Wu, L., Liu, H., Ma, X., Li, Q., Wu, M., Wang, W., Li, J., & Wu, H. (2022) · Helicobacter · doi:10.1111/hel.12944 · Cited by 46
Progressive senescence programs induce intrinsic vulnerability to aging-related female breast cancer
Bai, H., Liu, X., Lin, M., Meng, Y., Tang, R., Guo, Y., Li, N., Clarke, M. F., & Cai, S. (2024) · Nature Communications · doi:10.1038/s41467-024-49106-2 · Cited by 42
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
Gergues, M., Bari, R., Koppisetti, S., Gosiewska, A., Kang, L., & HARIRI, R. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565278 · Cited by 52
New Insights on Molecular Mechanisms of Renal Aging
Schmitt, R., & Melk, A. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04214.x · Cited by 40
Epigenetic Control of Hematopoietic Stem Cell Aging The Case of Ezh2
de Haan, G., & GERRITS, A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1392.008 · Cited by 42
James, E. L., Lane, J. A. E., Michalek, R. D., Karoly, E. D., & Parkinson, E. K. (2016) · Scientific Reports · doi:10.1038/srep38489 · Cited by 40
Huang, Y. X. R., Liu, Y., Yu, S., Li, W., Li, J., Zhao, B., Hu, X., & Jin, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5628946 · Cited by 40
Prognostic implications of cellular senescence in resected non-small cell lung cancer
Domen, A., Deben, C., Pauw, I. D., Hermans, C., Lambrechts, H. A. J., Verswyvel, J., Siozopoulou, V., Pauwels, P., Demaria, M., van de Wiel, M., et al. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-192 · Cited by 42
Centella asiatica extracts modulate hydrogen peroxide-induced senescence in human dermal fibroblasts
Kim, Y., Cha, H. J., Nam, K. H., Yoon, Y., Lee, H., & An, S. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01388.x · Cited by 50
Lee, S. S., Vũ, T. T., Weiss, A. S., & Yeo, G. C. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151331 · Cited by 45
Sakaki, M., Ebihara, Y., Okamura, K., Nakabayashi, K., Igarashi, A., Matsumoto, K., Hata, K., Kobayashi, Y., & Maehara, K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171431 · Cited by 39
Pathways from senescence to melanoma: focus on MITF sumoylation
Leclerc, J., Ballotti, R., & Bertolotto, C. (2017) · Oncogene · doi:10.1038/onc.2017.292 · Cited by 46
Senescence-mediated anticancer effects of quercetin
Özsoy, S., Becer, E., & Vatansever, H. S. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.04.007 · Cited by 46
Age-Related Midbrain Inflammation and Senescence in Parkinson’s Disease
Russo, T., & Rießland, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.917797 · Cited by 40
Senescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
Piskorz, W. M., & Cechowska‐Pasko, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911082 · Cited by 44
Gene regulatory network underlying the immortalization of epithelial cells
Méndez-López, L. F., Dávila-Velderrain, J., Domínguez‐Hüttinger, E., Enríquez-Olguín, C., Martínez‐García, J. C., & Alvarez-Buylla, E. R. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0393-5 · Cited by 43
Blagosklonny, M. V. (2012) · Oncotarget · doi:10.18632/oncotarget.890 · Cited by 39
Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target
Narasimhan, A., Flores, R. R., Camell, C. D., Bernlohr, D., Robbins, P. D., & Niedernhofer, L. J. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01493-w · Cited by 46
Beyond SAHF: An integrative view of chromatin compartmentalization during senescence
Olan, I., Handa, T., & Narita, M. (2023) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2023.102206 · Cited by 50
Self-citationPlacental Senescence and the Two‐Stage Model of Preeclampsia
Sugulle, M., Fiskå, B. S., Jacobsen, D. P., Fjeldstad, H. E., & Staff, A. C. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.13904 · Cited by 49
Silencing Nuclear Pore Protein Tpr Elicits a Senescent-Like Phenotype in Cancer Cells
David‐Watine, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022423 · Cited by 39
PML-IV functions as a negative regulator of telomerase by interacting with TERT
Oh, W., Ghim, J., Lee, E., Yang, M.-R., Kim, E. T., Ahn, J.-H., & Song, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.048066 · Cited by 43
Hou, J., Jeon, B.-M., Yun, Y. J., Cui, C.-H., & Kim, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051244 · Cited by 40
Dobbelstein, M., & Levine, A. J. (2020) · Cancer Science · doi:10.1111/cas.14433 · Cited by 37
Saleh, T., Alhesa, A., Al-Balas, M., Abuelaish, O. M., Mansour, A. T., Awad, H., El‐Sadoni, M., Carpenter, V. J., & Azab, B. (2021) · Bioscience Reports · doi:10.1042/bsr20210079 · Cited by 40
Metabolic Alterations in Cellular Senescence: The Role of Citrate in Ageing and Age-Related Disease
Mycielska, M. E., James, E. N., & Parkinson, E. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073652 · Cited by 40
p16/p53 expression and telomerase activity in immortalized human dental pulp cells
Egbuniwe, O., Idowu, B. D., Funes, J. M., Grant, A. D., Renton, T. F., & Silvio, L. D. (2011) · Cell Cycle · doi:10.4161/cc.10.22.18093 · Cited by 41
Oncogenic transformation of human cells: shortcomings of rodent model systems
Akagi, T. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.001 · Cited by 42
Mazzucco, A. E., Smogorzewska, A., Kang, C., Luo, J., Schlabach, M. R., Xu, Q., Patel, R., & Elledge, S. J. (2017) · Genes & Development · doi:10.1101/gad.304857.117 · Cited by 35
Emerging Roles of Vitamin B12 in Aging and Inflammation
Simonenko, S. Y., Bogdanova, D. A., & Kuldyushev, N. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095044 · Cited by 45
The impact of ageing mechanisms on musculoskeletal system diseases in the elderly
Cai, Y., Han, Z., Cheng, H., Li, H., Wang, K., Chen, J., Liu, Z., Xie, Y., Lin, Y., Zhou, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405621 · Cited by 57
Senescence and pre-malignancy: How do tumors progress?
Saab, R. H. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.013 · Cited by 42
Metadata
- Authors
- Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Salk Institute for Biological Studies (US)
- Cold Spring Harbor Laboratory (US)
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- Venue
- The EMBO Journal
- Published
- 2003-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 4212-4222
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC175806
- OpenAlex
- W2061619522
- Cited by
- 1,457
- References
- 61
- Citations by year
- 2026: 46 · 2025: 58 · 2024: 87 · 2023: 94 · 2022: 77 · 2021: 107 · 2020: 77 · 2019: 77 · 2018: 78 · 2017: 63 · 2016: 74 · 2015: 55 · 2014: 59 · 2013: 54 · 2012: 69
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Funders
- Uehara Memorial Foundation
- National Institute on Aging (R56AG009909, R56AG016379, AG-09909, AG-16379, R01AG016379, R37AG009909)
- National Cancer Institute (P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, replicative senescence, p53, p16, retinoblastoma protein, telomere dysfunction, telomerase, oncogenic Ras, growth arrest, senescence reversal, mammary epithelial cells, fibroblasts, tumor suppression
- MeSH terms
- Breast, Cell Line, Epithelial Cells, Fibroblasts, Humans, Luminescent Proteins, Models, Biological, Genes, ras, Signal Transduction, Tumor Suppressor Protein p53, Lentivirus Infections, Cellular Senescence, Telomerase, Cyclin-Dependent Kinase Inhibitor p16, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.